Computational Biology (Pharmacodynamics, Cellular Modeling, Computational Genomics, Proteomics, Pharmacogenomics, Pharmacokinetics, Human Simulation Software, Drug Discovery & Development) Information and Market Trend - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
"Computational
Biology (Pharmacodynamics, Cellular Modeling, Computational Genomics,
Proteomics, Pharmacogenomics, Pharmacokinetics, Human Simulation
Software, Drug Discovery & Development) Market - Global Industry
Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
Description-
The
computational biology market is predicted to have a notable growth
owing to its wide use by biotechnology and pharmaceutical companies
to reduce the incidences of late stage failures of their drugs and to
thereby curb R&D expenditure. Computational biology is also
assisting in reducing the extensive use of humans in trials and is
therefore useful for pediatric trials, trials on pregnant women and
orphan disease research.
Get
Sample
Report
With TOC @
http://www.researchmoz.us/enquiry.php?type=S&repid=167571
This
report analyses the global market for computational biology by two
main types of studies-cellular modeling and disease modeling. Each of
these segments has been further analyzed by various studies with use
of simulation, right from drug discovery to drug development. The
market has also been bifurcated on the basis of tools which include
databases, software and IT infrastructure. The computational biology
services market highlights the trend of in-house and contract
computational biology. The end users market studies the usage pattern
of academic research institutes and commercial industry. All the
above mentioned segments are analyzed on the basis of market size in
terms of USD million and their forecasts for the period 2012 to 2018
have also been provided. The CAGR (%) for each market segment has
been estimated for the forecast period 2012 to 2018, considering 2011
as the base year.
Geographically,
this market has been divided into four major regions which include
North America, Europe, Asia and RoW (Rest of the world). Market
sizes, forecasts and % CAGR for each region have been provided. The
major drivers, restraints, challenges and growth opportunities and
other qualitative dynamics have been considered in the market
overview section of this report.
The
competitive landscape of this industry has been covered under market
share analysis by key players. Our recommendation chapter provides
assistance to industry players on ways to enter this market or to
establish sustainable competitive advantage.
The
global computational biology market is segmented as follows:
Computational
Biology Market, By Types
- Cellular & Biological Simulation
- Computational Genomics
- Computational Proteomics
- Pharmacogenomics
- Others (Transcriptomics/ Metabolomics)
- Disease Modeling and Simulation
- Drug Discovery
- Target Identification
- Target Validation
- Lead Discovery
- Lead Optimization
- Drug Development
- Preclinical
- Pharmacokinetics
- Pharmacodynamics
- Clinical trials
- Phase I
- Phase II
- Phase III
- Human Body Simulation Software
Computational Biology Market, By Services
- In-House
- Contract
Computational Biology Market, By End Users
- Academics
- Industry/ Commercial Players
Computational Biology Market, By Geography
- North America
- Europe
- Asia
- Rest of the World (RoW)
- Industry/ Commercial Players
Comments
Post a Comment